Request Your Free White Paper Now:
"Incidental Findings in Clinical Genomics: How to Handle Incidental Findings and When Information Should Be Disclosed to Patients"
This paper explores the issues surrounding defining and managing incidental findings (IFs) in clinical genomics
This paper explores the issues surrounding defining and managing incidental findings (IFs) in clinical genomics, providing insights about:
- Why do we detect IFs during the course of genetic testing?
- Is the term "incidental" an adequate one?
- The uncertainties associated with disclosure of IFs: clinical utility as a determinant
- Ethical issues surrounding Ifs: balancing actionability and patient autonomy
- What are the ways of dealing with IFs?
Offered Free by: Qiagen
See All Resources from: Qiagen